Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP Vivasmental-health

GP Vivas · mental-health

Anxiety disorders — structured viva

Structured oral on anxiety disorders: differentiating GAD, panic and social anxiety, defending GAD-7 bands with Cochrane accuracy data, arguing the stepped-care ladder and sertraline-first pharmacotherapy, handling benzodiazepine pressure, and closing on measurement-based relapse prevention.

structured clinical oral3 min readVerification in progress

Target exams

RACGP CCEFRACGP oralsMRCGP SCA
On this page
Study tools

Target exams

RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'Half your waiting room is anxious. Why do you need guidelines to prescribe a test and a tablet?' The viva branches through classification and screening, mimics, stepped care, drug sequencing, benzodiazepine boundaries, and relapse prevention.

Stem

You are the GP. Anxious presentations fill the morning list; the registrar asks why each one needs its own pathway. [1]

Branch A — Classification that changes treatment

Examiner: Are GAD, panic and social anxiety really different diseases? [1]

Strong answer: They are distinct symptom syndromes with shared first-line treatments. GAD: excessive, hard-to-control worry across domains more days than not for at least six months. Panic disorder: recurrent unexpected discrete attacks plus concern about attacks or avoidance. Social anxiety: fear of scrutiny with avoidance. Specific phobia and agoraphobia differ by trigger. The WFSBP guideline evaluated over 1000 RCTs across these conditions and converged on one message — SSRIs/SNRIs first-line drugs, CBT first-line psychotherapy — which is precisely why the grouping matters less than matching the right modality to severity and preference. [1]

General Practice Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References17ShowHide
  1. [2]Spitzer RL, Kroenke K, Williams JB et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of internal medicine, 2006.PMID 16717171
  2. [3]Aktürk Z, Hapfelmeier A, Fomenko A et al. Generalized Anxiety Disorder 7-item (GAD-7) and 2-item (GAD-2) scales for detecting anxiety disorders in adults. The Cochrane database of systematic reviews, 2025.PMID 40130828
  3. [4]Slee A, Nazareth I, Bondaronek P et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet, 2019.PMID 30712879
  4. [5]Lewis G, Duffy L, Ades A et al. The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA). The lancet. Psychiatry, 2019.PMID 31543474
  5. [6]Cardoner N, Gutiérrez-Rojas L, Saiz P et al. Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness. Frontiers in pharmacology, 2025.PMID 39989902
  6. [7]Kong W, Deng H, Wan J et al. Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials. Frontiers in pharmacology, 2020.PMID 33343351
  7. [9]Matsumoto K, Hamatani S, Shimizu E Effectiveness of Videoconference-Delivered Cognitive Behavioral Therapy for Adults With Psychiatric Disorders. Journal of medical Internet research, 2021.PMID 34898445
  8. [10]Farris SG, Derby L, Kibbey MM Getting comfortable with physical discomfort: A scoping review of interoceptive exposure in physical and mental health conditions. Psychological bulletin, 2025.PMID 40014537
  9. [12]Lewis G, Marston L, Duffy L et al. Maintenance or Discontinuation of Antidepressants in Primary Care. The New England journal of medicine, 2021.PMID 34587384
  10. [13]Krijnen-de Bruin E, Scholten W, Muntingh A et al. Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis. PloS one, 2022.PMID 35960783
  11. [14]Remes O, Brayne C, van der Linde R et al. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain and behavior, 2016.PMID 27458547
  12. [16]Nascimento AOD, Silva CECD, Silva MLD et al. The Effects of Caffeine on Anxiety Behavior in Healthy Individuals: A Systematic Review of the Literature. Stress and health, 2026.PMID 41549915
  13. [17]Struijs SY, de Jong PJ, Jeronimus BF et al. Psychological risk factors and the course of depression and anxiety disorders: A review of 15 years NESDA research. Journal of affective disorders, 2021.PMID 34706448
  14. [18]García Álvarez Á, Riera Serra P, Ricci-Cabello I et al. Effectiveness and safety of focused deprescribing interventions targeting specific drug classes in older adults across clinical settings. Age and ageing, 2026.PMID 42607278
  15. [8]Zainal NH, Soh CP, Van Doren N et al. Do the effects of internet-delivered cognitive-behavioral therapy (i-CBT) last after a year and beyond? A meta-analysis of 154 randomized controlled trials (RCTs). Clinical psychology review, 2024.PMID 39579466
  16. [15]Remes O, Wainwright N, Surtees P et al. Generalised anxiety disorder and hospital admissions: findings from a large, population cohort study. BMJ open, 2018.PMID 30368445
  17. [1]Bandelow B, Allgulander C, Baldwin DS et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders - Version 3. Part I: Anxiety disorders. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2023.PMID 35900161
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAdult depression — structured vivamental-healthNextFirst-episode psychosis — structured vivamental-health